2 results
Approved WMORecruiting
This study is looking at how safe the combination of the experimental drugs dostarlimab, belrestotug and GSK6097608 is in patients with previously untreated, advanced or metastatic non-small cell lung cancer. And how well the combination works. We…
Approved WMORecruiting
To assess if PCI optimization using High Definition (HD)-IVUS in patients with a post-PCI FFR below 0.90 will improve target vessel failure.